Epidemiology of adrenocortical carcinoma

Adrenocortical Carcinoma: Basic Science and Clinical Concepts

Volumn , Issue , 2011, Pages 23-29

  Fassnacht, Martin ^a   Allolio, Bruno ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84865222856     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-77236-3_3     Document Type: Chapter

References (40)

1. Bovio S et al (2006) Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest 29(4):298-302
2. Grumbach MM et al (2003) Management of the clinically inapparent adrenal mass (incidentaloma). Ann Intern Med 138(5):424-429
3. Kloos RT et al (1995) Incidentally discovered adrenal masses. Endocr Rev 16(4):460-484
4. Mansmann G et al (2004) The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 25(2):309-340
5. Song JH et al (2008) The incidental adrenal mass on CT: prevalence of adrenal disease in 1, 049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol 190(5):1163-1168
6. Terzolo M et al (1997) Prevalence of adrenal carcinoma among incidentally discovered adrenal masses. A retrospective study from 1989 to 1994. Gruppo Piemontese Incidentalomi Surrenalici. Arch Surg 132(8):914-919
7. National-Cancer-Institute (1975) Third national cancer survey: incidence data. DHEW Publ. No. (NIH) 75-787. NCI monograph: 41
8. Golden SH et al (2009) Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab 94(6):1853-1878
9. Kebebew E et al (2006) Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress? World J Surg 30(5):872-878
10. Michalkiewicz E et al (2004) Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. J Clin Oncol 22(5):838-845
11. Pianovski MA et al (2006) Mortality rate of adrenocortical tumors in children under 15 years of age in Curitiba, Brazil. Pediatr Blood Cancer 47(1):56-60
12. Ribeiro RC et al (2001) An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci USA 98(16):9330-9335
13. Wajchenberg B et al (2000) Adrenocortical carcinoma: clinical and laboratory observations. Cancer 88(4):711-736
14. Bilimoria KY et al (2008) Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Cancer 113(11):3130-3136
15. Fassnacht M, Allolio B (2009) Clinical management of adrenocortical carcinoma. Best Pract Res Clin Endocrinol Metab 23(2):273-289
16. Fassnacht M et al (2009) Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a revised TNM classification. Cancer 115(2):243-250
17. Icard P et al (2001) Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg 25(7):891-897
18. Koschker AC et al (2006) Adrenocortical carcinoma - improving patient care by establishing new structures. Exp Clin Endocrinol Diabetes 114(2):45-51
19. Luton JP et al (1990) Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 322(17):1195-1201
20. Icard P et al (1992) Survival rates and prognostic factors in adrenocortical carcinoma. World J Surg 16(4):753-758
21. Wooten MD, King DK (1993) Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer 72(11):3145-3155
22. Montanaro D et al (2005) Antiestrogens upregulate estrogen receptor beta expression and inhibit adrenocortical H295R cell proliferation. J Mol Endocrinol 35(2):245-256
23. Somjen D et al (2003) Carboxy derivatives of isoflavones as affinity carriers for cytotoxic drug targeting in adrenocortical H295R carcinoma cells. J Endocrinol 179(3):395-403
24. Hsing AW et al (1996) Risk factors for adrenal cancer: an exploratory study. Int J Cancer 65(4):432-436
25. Chow WH et al (1996) Smoking and adrenal cancer mortality among United States veterans. Cancer Epidemiol Biomarkers Prev 5(2):79-80
26. Dalbey WE et al (1980) Chronic inhalation of cigarette smoke by F344 rats. J Natl Cancer Inst 64(2):383-390
27. Kuper H et al (2002) Tobacco use and cancer causation: association by tumour type. J Intern Med 252(3):206-224
28. Hutter AM, Jr, Kayhoe DE (1966) Adrenal cortical carcinoma. Clinical features of 138 patients. Am J Med 41(4):572-580
29. Allolio B (2001) Adrenal incidentalomas. In: Margioris AN, Chrousos GP (eds) Adrenal disorders. Humana, Totawa, NJ, pp 249-261
30. Hamwi GJ et al (1957) Does adrenocortical hyperplasia result in adrenocortical carcinoma. N Engl J Med 257(24):1153-1157
31. Abiven G et al (2006) Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. J Clin Endocrinol Metab 91(7):2650-2655
32. Kendrick ML et al (2001) Adrenocortical carcinoma: surgical progress or status quo? Arch Surg 136(5):543-549
33. Schulick RD, Brennan MF (1999) Adrenocortical carcinoma. World J Urol 17(1):26-34
34. Durusu M et al (2002) Adrenal cortical carcinoma presenting initially with radius metastasis. Clin Oncol (R Coll Radiol) 14(1):83-84
35. Solans R et al (2001) Bone metastases as presentation of adrenocortical carcinoma. Med Clin (Barc) 116(2):76-77
36. Bellantone R et al (1997) Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma. Surgery 122(6):1212-1218
37. Haak HR et al (1994) Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. Br J Cancer 69(5):947-951
38. Pommier RF, Brennan MF (1992) An eleven-year experience with adrenocortical carcinoma. Surgery 112(6):963-970; discussion 970-971
39. Soreide JA et al (1992) Adrenal cortical carcinoma in Norway, 1970-1984. World J Surg 16(4):663-667; discussion 668
40. Venkatesh S et al (1989) Adrenal cortical carcinoma. Cancer 64(3):765-769